ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,796Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 972

$966K Total Retail Price of All Prescriptions

Rank: 74 out of 972

614 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 614 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 614 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 11,421 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
AMLODIPINE BESYLATE 797 648 1 4
SIMVASTATIN 642 558 2 2
LISINOPRIL 636 491 3 1
HYDROCHLOROTHIAZIDE 527 420 4 10
METFORMIN HCL 474 328 5 8
FUROSEMIDE 376 290 6 7
LEVOTHYROXINE SODIUM 350 240 7 3
HYDROCODONE-ACETAMINOPHEN 338 136 S3 8 6
OMEPRAZOLE 307 208 9 5
ZOLPIDEM TARTRATE 278 138 10 23
CLONIDINE HCL 258 215 11 57
TRAMADOL HCL 257 147 12 15
GABAPENTIN 250 150 13 14
FLUTICASONE PROPIONATE 235 112 14 31
METOPROLOL TARTRATE 227 188 15 9
LOSARTAN POTASSIUM 220 172 16 17
METOPROLOL SUCCINATE 205 162 17 16
ATORVASTATIN CALCIUM 199 121 18 11
RANITIDINE HCL 193 116 19 24
GLIMEPIRIDE 191 168 20 34
NAPROXEN 182 112 21 71
CRESTOR 173 98 22 33
DIOVAN 164 120 23 48
CYCLOBENZAPRINE HCL 162 50 R 24 53
LOVASTATIN 159 133 25 22
ALENDRONATE SODIUM 143 124 26 27
PROAIR HFA 142 73 27 47
POTASSIUM CHLORIDE 132 104 28 13
CIPROFLOXACIN HCL 124 95 29 63
NEXIUM 124 82 29 30
PRAVASTATIN SODIUM 124 105 29 20
ATENOLOL 122 116 32 18
BYSTOLIC 121 114 33 102
DOXAZOSIN MESYLATE 119 105 34 82
KLOR-CON M20 114 86 35 78
QUINAPRIL HCL 109 87 36 95
DONEPEZIL HCL 109 106 36 26
CARVEDILOL 108 84 38 21
JANUVIA 108 60 38 75
AMLODIPINE BESYLATE-BENAZEPRIL 105 89 40 114
CLOPIDOGREL 100 85 41 37
NIFEDIPINE ER 99 97 42 116
AZITHROMYCIN 96 59 43 42
ADVAIR DISKUS 93 56 44 45
GLIPIZIDE ER 89 67 45 103
WARFARIN SODIUM 89 66 45 12
VERAPAMIL ER 88 68 47 108
IRBESARTAN 86 85 48 337
TRIAMTERENE-HCTZ 85 52 49 39
GLYBURIDE 83 69 R 50 70
CARISOPRODOL 80 25 R 51 110
AMITRIPTYLINE HCL 78 42 R 52 58
LOSARTAN-HYDROCHLOROTHIAZIDE 78 51 52 61
ALLOPURINOL 77 61 54 28
TAMSULOSIN HCL 76 37 55 29
KLOR-CON 10 76 56 55 68
SERTRALINE HCL 75 24 57 25
LANTUS SOLOSTAR 74 16 58 86
PEN NEEDLE 74 13 58 99
PREMARIN 72 41 R 60 153
DIOVAN HCT 71 43 61 122
CITALOPRAM HBR 68 31 62 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 44 62 32
PLAVIX 65 56 64 55
NIASPAN 63 15 65 144
IBUPROFEN 61 19 66 92
NOVOLOG FLEXPEN 60 12 67 206
CYMBALTA 60 26 67 49
INSULIN SYRINGE 60 27 67 84
SYNTHROID 60 57 67 51
DILTIAZEM 24HR ER 59 45 71 207
MELOXICAM 59 21 71 36
POLYETHYLENE GLYCOL 3350 59 18 71 67
SINGULAIR 59 33 71 81
AVAPRO 58 58 75 459
LORATADINE 58 50 75 354
ENALAPRIL MALEATE 57 47 77 50
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 38 78 109
AMOX TR-POTASSIUM CLAVULANATE 52 28 79 157
ROPINIROLE HCL 52 25 79 72
LIDODERM 51 23 81 115
DIGOXIN 51 33 81 52
BENICAR 51 46 81 133
TRIAMTERENE-HYDROCHLOROTHIAZID 50 40 84 152
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.